Clopikind 150mg Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Clopidogrel (150mg)
Overview Clopikind 150mg Tablet
CardioProtect 150mg tablets are antiplatelet agents, reducing the risk of dangerous blood clot formation within blood vessels. This significantly lowers the likelihood of heart attack or stroke, making it a cornerstone medication in cardiovascular protection. CardioProtect 150mg is prescribed for individuals at elevated risk of heart disease, including those with peripheral artery disease (circulatory issues from narrowed vessels), recent heart attack or stroke, arrhythmias, and post-stenting. It's also used alongside other medications to manage heart attacks and unstable angina. This medication can be administered with or without food, consistently at the same time daily. Continued use is vital, even when feeling well, as discontinuation increases the risk of cardiovascular events. The most frequent side effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be slower. While generally mild and self-resolving, persistent or concerning bleeding necessitates immediate medical attention. This medication is contraindicated for individuals with active internal bleeding (e.g., gastric ulcers, intracranial hemorrhage). Prior to initiation, inform your physician of any bleeding disorders, recent major trauma, or upcoming surgery. Temporary discontinuation may be necessary before scheduled procedures.
Uses of Clopikind 150mg Tablet
Avert cardiac events and cerebrovascular accidents.
Major Benefits of Clopikind 150mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Clopikind 150mg Tablet whole; do not chew, crush, or divide it. While it can be taken with or without food, consistency is key—administer it at the same time each day.
Common Side effects of Clopikind 150mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Clopikind 150mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Clopikind 150mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Clopikind 150mg Tablet works:
Ticagrelor 150mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous thrombus formation and consequently lowering the likelihood of myocardial infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Clopikind 150mg tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Clopikind 150mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of the medication Clopikind 150mg tablets while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Clopikind 150mg Tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Clopikind 150mg tablets without requiring a dosage modification.
LiverSAFE IF PRESCRIBED
Clopikind 150mg tablets may be administered to patients with hepatic impairment without modification of the prescribed dosage.
What if you forget to take Clopikind 150mg Tablet :
Should you forget a Clopikind 150mg Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Clopikind 150mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alpha esters |
| Developing Habits | No. |
| Type of Therapy | KINSHIP |
| Behavior Class | ADP receptor antagonists (P2Y12 inhibitors) |



